Benign Nonmeningeal Tumors of the Cavernous Sinus

Benign Nonmeningeal Tumors of the Cavernous Sinus AbstractOBJECTIVEResection of benign cavernous sinus tumors with minimum morbidity and mortality is increasingly more common. Although meningiomas have dominated most discussions, numerous nonmeningeal tumors also deserve attention because they are generally more amenable to radical surgical resection.METHODSWe reviewed the records of 40 patients (19 female and 21 male patients) who were treated surgically during a 15-year period for benign, nonmeningeal tumors of the cavernous sinus. Invasive pituitary adenomas (14 cases) and trigeminal schwannomas (13 cases) comprised the majority of tumors; the remaining tumor types were hemangioma, neurofibroma, juvenile angiofibroma, dermoid tumor, giant cell tumor, chondromyxofibroma, and chondroma. Patient age ranged from 7 to 65 years (mean, 37 yr).RESULTSAll patients underwent surgery, the intent being total resection. Total resection was achieved in 33 (82.5%) of the 40 patients. Follow-up was achieved via a combination of direct patient visit or phone interview or via the referring physician. Eight patients had undergone previous surgery elsewhere, which correlated closely with complications and neurophthalmological outcomes but did not affect resectability. Postoperatively, 89.7% of the patients had either stable or improved extraocular muscle function compared with their preoperative statuses. Forty percent of the patients experienced improvement of their preoperative extraocular muscle deficits. Complications included cerebrospinal fluid leak (three cases), postoperative hemorrhage (one case), fat embolism (one case), perforator distribution infarct (one case), hydrocephalus requiring ventriculoperitoneal shunting (two cases), transient hemiparesis (one case), and diabetes insipidus (one case).CONCLUSIONWe conclude that benign nonmeningeal tumors of the cavernous sinus can be safely and radically removed and result in good long-term neuro-ophthalmological function and low morbidity and mortality. Furthermore, when compared with our previously reported results for cavernous sinus meningiomas, benign nonmeningeal tumors of the cavernous sinus carry a better chance of total removal, a lower incidence of postoperative ocular dysfunction, and a higher rate of recovery of preoperative cranial nerve deficits (7). http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Neurosurgery Oxford University Press

Benign Nonmeningeal Tumors of the Cavernous Sinus

Benign Nonmeningeal Tumors of the Cavernous Sinus

M a r k B . E i s e n b e r g , M . D . , O s s a m a A l - M e f t y , M . D . , F r a n c o D e M o n t e , M . D . , G . T i m B u r s o n , M . D . Skull Base Surgery Center (M BE), North Shore U niversity Hospital, Manhasset, N ew Yo rk; Department of Neurosurgery (O A-M , C T B ), U niversity ot Arkansas for M edical Sciences, Little Rock, Arkansas; and Department of Neurosurgery (FD ), U niversity of Texas M .D . Anderson C ancer Center, Houston, Texas OBJECTIVE: R e s e c tio n o f b e n ig n c a v e r n o u s sinus t u m o r s w i t h m i n i m u m m o r b i d i t y a n d m o r t a l i t y is in c r e a s in g ly m o r e c o m m o n . A lt h o u g h m e n in g io m a s h a v e d o m i n a t e d m o s t discussions, n u m e r o u s n o n m e n in g e a l t u m o r s also d e s e r v e a tte n tio n b e c a u s e t h e y a r e g e n e r a lly m o r e a m e n a b l e to r a d ic a l s u rg ic a l r e s e c tio n . M E T H O D S : W e r e v i e w e d t h e r e c o r d s o f 4 0 p a tie n ts ( 1 9 f e m a le a n d 21 m a le p a tie n ts ) w h o w e r e t r e a t e d s u r g ic a lly d u rin g a 1 5 - y e a r p e r io d f o r b e n ig n , n o n m e n in g e a l tu m o r s o f th e c a v e r n o u s sinus. In v a s iv e p i t u i t a r y a d e n o m a s ( 1 4 cases) an d t r ig e m i n a l s c h w a n n o m a s ( 1 3 cases) c o m p r is e d th e m a j o r i t y o f t u m o r s ; t h e r e m a i n i n g t u m o r ty p e s w e r e h e m a n g io m a , n e u r o f i b r o m a , j u v e n i l e a n g i o f i b r o m a , d e r m o id t u m o r , g ia n t c e ll t u m o r , c h o n d r o m y x o f i b r o m a , a n d c h o n d r o m a . P a t ie n t a g e r a n g e d f r o m 7 to 6 5 y e a rs ( m e a n , 3 7 y r ) . RESULTS: A ll p atien ts u n d e r w e n t su rg ery, th e in te n t b e in g to ta l re se c tio n . T o ta l re s e c tio n w as a c h ie v e d in 3 3 ( 8 2 . 5 % ) o f the 4 0 patients. F o llo w -u p w a s a c h ie v e d v ia a c o m b in a tio n o f...
Loading next page...
 
/lp/ou_press/benign-nonmeningeal-tumors-of-the-cavernous-sinus-HqsbCoxzfd
Publisher
Congress of Neurological Surgeons
Copyright
© Published by Oxford University Press.
ISSN
0148-396X
eISSN
1524-4040
D.O.I.
10.1097/00006123-199905000-00008
Publisher site
See Article on Publisher Site

Abstract

AbstractOBJECTIVEResection of benign cavernous sinus tumors with minimum morbidity and mortality is increasingly more common. Although meningiomas have dominated most discussions, numerous nonmeningeal tumors also deserve attention because they are generally more amenable to radical surgical resection.METHODSWe reviewed the records of 40 patients (19 female and 21 male patients) who were treated surgically during a 15-year period for benign, nonmeningeal tumors of the cavernous sinus. Invasive pituitary adenomas (14 cases) and trigeminal schwannomas (13 cases) comprised the majority of tumors; the remaining tumor types were hemangioma, neurofibroma, juvenile angiofibroma, dermoid tumor, giant cell tumor, chondromyxofibroma, and chondroma. Patient age ranged from 7 to 65 years (mean, 37 yr).RESULTSAll patients underwent surgery, the intent being total resection. Total resection was achieved in 33 (82.5%) of the 40 patients. Follow-up was achieved via a combination of direct patient visit or phone interview or via the referring physician. Eight patients had undergone previous surgery elsewhere, which correlated closely with complications and neurophthalmological outcomes but did not affect resectability. Postoperatively, 89.7% of the patients had either stable or improved extraocular muscle function compared with their preoperative statuses. Forty percent of the patients experienced improvement of their preoperative extraocular muscle deficits. Complications included cerebrospinal fluid leak (three cases), postoperative hemorrhage (one case), fat embolism (one case), perforator distribution infarct (one case), hydrocephalus requiring ventriculoperitoneal shunting (two cases), transient hemiparesis (one case), and diabetes insipidus (one case).CONCLUSIONWe conclude that benign nonmeningeal tumors of the cavernous sinus can be safely and radically removed and result in good long-term neuro-ophthalmological function and low morbidity and mortality. Furthermore, when compared with our previously reported results for cavernous sinus meningiomas, benign nonmeningeal tumors of the cavernous sinus carry a better chance of total removal, a lower incidence of postoperative ocular dysfunction, and a higher rate of recovery of preoperative cranial nerve deficits (7).

Journal

NeurosurgeryOxford University Press

Published: May 1, 1999

There are no references for this article.

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Unlimited reading

Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.

Stay up to date

Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.

Organize your research

It’s easy to organize your research with our built-in tools.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

Monthly Plan

  • Read unlimited articles
  • Personalized recommendations
  • No expiration
  • Print 20 pages per month
  • 20% off on PDF purchases
  • Organize your research
  • Get updates on your journals and topic searches

$49/month

Start Free Trial

14-day Free Trial

Best Deal — 39% off

Annual Plan

  • All the features of the Professional Plan, but for 39% off!
  • Billed annually
  • No expiration
  • For the normal price of 10 articles elsewhere, you get one full year of unlimited access to articles.

$588

$360/year

billed annually
Start Free Trial

14-day Free Trial